Guo-Ming Shi Selected Research

Guo-Ming Shi Research Topics

Disease

48	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 06/2008
47	Neoplasms (Cancer) 01/2024 - 06/2008
14	Neoplasm Metastasis (Metastasis) 05/2023 - 06/2008
8	Cholangiocarcinoma 01/2024 - 03/2015
4	Liver Failure 12/2022 - 01/2019
2	Liver Diseases (Liver Disease) 01/2022 - 01/2019
2	Infections 01/2019 - 01/2019
2	Carcinogenesis 10/2018 - 08/2017
2	Lymphatic Metastasis 01/2014 - 08/2012
1	Disease Progression 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Ischemia 05/2021
1	Thrombosis (Thrombus) 10/2020
1	Hemorrhage 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Portal Hypertension 01/2020
1	Hyperbilirubinemia 01/2019
1	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 01/2019
1	Hyperplasia 10/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Coinfection 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Hepatitis 01/2017

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2008
6	Proteins (Proteins, Gene)FDA Link 03/2019 - 12/2010
5	Sorafenib (BAY 43-9006)FDA Link 04/2022 - 10/2011
5	TetraspaninsIBA 01/2019 - 02/2009
3	Circular RNAIBA 02/2024 - 01/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 10/2011
3	RNA (Ribonucleic Acid)IBA 05/2023 - 10/2009
3	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2011
3	UbiquitinIBA 05/2016 - 11/2012
3	IntegrinsIBA 02/2016 - 11/2008
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2015 - 06/2008
3	Chloroquine (Aralen)FDA LinkGeneric 11/2012 - 10/2011
3	Small Interfering RNA (siRNA)IBA 12/2011 - 10/2009
2	lenvatinibIBA 01/2024 - 01/2023
2	5-hydroxymethylcytosineIBA 01/2023 - 04/2015
2	LigandsIBA 01/2021 - 07/2012
2	Long Noncoding RNAIBA 01/2020 - 01/2019
2	VimentinIBA 01/2020 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	mortalinIBA 01/2019 - 08/2017
2	BilirubinIBA 01/2019 - 01/2017
2	Selenium-Binding ProteinsIBA 01/2018 - 01/2018
2	Cadherins (E-Cadherin)IBA 01/2014 - 10/2009
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2011 - 07/2010
1	Gemcitabine FDA Link 01/2024
1	TCF Transcription FactorsIBA 10/2023
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 10/2023
1	PlasticsIBA 10/2023
1	InflammasomesIBA 05/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2023
1	pemigatinibIBA 01/2023
1	toripalimabIBA 01/2023
1	KSR-1 protein kinaseIBA 04/2022
1	avatrombopagIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 11/2021
1	CTLA-4 AntigenIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	apatinibIBA 10/2020
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	TerlipressinIBA 01/2020
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 01/2020
1	centromere protein FIBA 07/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Sincalide FDA Link 01/2019
1	GlucocorticoidsIBA 01/2019
1	Competitive Endogenous RNAIBA 01/2019
1	LipidsIBA 10/2018
1	Nonesterified Fatty Acids (NEFA)IBA 10/2018
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	NLR ProteinsIBA 01/2018
1	NucleotidesIBA 01/2018
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017
1	Hepatitis B e AntigensIBA 01/2017
1	AlbuminsIBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2016
1	Annexin A2 (Annexin II)IBA 05/2016
1	Monoclonal AntibodiesIBA 02/2016
1	Tetraspanin 24IBA 02/2016
1	MAP Kinase Kinase Kinase 4IBA 12/2015
1	Growth Factor ReceptorsIBA 10/2015
1	Protein Tyrosine PhosphatasesIBA 10/2015
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 05/2015
1	human PSMC5 proteinIBA 05/2015
1	Ubiquitin-Specific ProteasesIBA 05/2015
1	Protein Isoforms (Isoforms)IBA 03/2015

Therapy/Procedure

10	Therapeutics 02/2024 - 10/2011
7	Hepatectomy 12/2022 - 03/2014
5	Immunotherapy 01/2023 - 11/2013
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
1	Length of Stay 01/2019